Cassava Sciences, Inc.SAVANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | -193.45% | -818.51% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -182.76% | -807.69% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -807.69% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +14.01% | +12.23% | +4.56% | +0.66% | +0.41% |
| Weighted Average Shares Diluted Growth | +14.01% | +9.43% | +4.56% | +0.66% | +0.41% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -1.56% | -13.60% | -41.97% | -83.66% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +3.87% | -9.50% | -44.42% | -42.02% | -24.87% |
| Book Value per Share Growth | -7.03% | +44.67% | -55.48% | -51.37% | -49.14% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +9.60% | -15.81% | -66.34% | -77.63% | -81.23% |
| SG&A Expenses Growth | -76.17% | +18.19% | -82.74% | -45.15% | +4587.06% |